# Randomized Trial Comparing Diltiazem and Metoprolol For Atrial Fibrillation Rate Control

> **NCT02025465** · PHASE4 · UNKNOWN · sponsor: **CAMC Health System** · enrollment: 150 (estimated)

## Conditions studied

- Atrial Fibrillation
- Atrial Flutter

## Interventions

- **DRUG:** Metoprolol
- **DRUG:** Diltiazem

## Key facts

- **NCT ID:** NCT02025465
- **Lead sponsor:** CAMC Health System
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-12
- **Primary completion:** 2018-12
- **Final completion:** 2018-12
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2017-08-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02025465

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02025465, "Randomized Trial Comparing Diltiazem and Metoprolol For Atrial Fibrillation Rate Control". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02025465. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*